In his harsh comments about the drug industry at a press conference earlier this month, President Trump declared that “pharma has a lot of lobbies and a lot of lobbyists and a lot of power.”
But how much, exactly? STAT analyzed lobbying disclosure filings updated this week to build an in-depth portrait of how the drug industry wielded its influence on the federal government in 2016.
All told, the industry’s two big trade groups spent a collective $29 million lobbying the federal government last year. And the top 15 pharma companies (by one measure) collectively spent an additional $80 million. Both figures are roughly consistent with 2015.